Abstract In adulthood, an induced nephron-specific deficiency of αENaC (Scnn1a) resulted in pseudohypoaldosteronism type 1 (PHA-1) with sodium loss, hyperkalemia, and metabolic acidosis that is rescued through high-sodium/low-potassium (HNa
Abstract In adulthood, an induced nephron-specific deficiency of αENaC (Scnn1a) resulted in pseudohypoaldosteronism type 1 (PHA-1) with sodium loss, hyperkalemia, and metabolic acidosis that is rescued through high-sodium/low-potassium (HNa + /LK + ) diet. In the present study, we addressed whether renal βENaC expression is required for sodium and potassium balance or can be compensated by remaining (α and γ) ENaC subunits using adult nephron-specific knockout (Scnn1b Pax8/LC1 ) mice. Upon induction, these mice present a severe PHA-1 phenotype with weight loss, hyperkalemia, and dehydration, but unlike the Scnn1a
Pax8/LC1 mice without persistent salt wasting. This is followed by a marked downregulation of STE20/SPS1-related proline-alanine-rich protein kinase (SPAK) and Na NCC expression. Since salt loss was minor, we applied a standard-sodium/LK + diet that efficiently rescued these mice resulting in normokalemia and normalization of NCC phosphorylation, but not total NCC expression. A further switch to LNa + / standard-K + diet induced again a severe PHA-1-like phenotype, but with only transient salt wasting indicating that low-K + intake is critical to decrease hyperkalemia in a NCC-dependent manner.
In conclusion, while the βENaC subunit plays only a minor role in sodium balance, severe hyperkalemia results in downregulation of NCC expression and activity. Our data demonstrate the importance to primarily correct the hyperkalemia with a lowpotassium diet that normalizes NCC activity.
Introduction
Two different forms of PHA-1 exist, the renal and the systemic form. The renal form (PHA-1) results from mutations in the mineralocorticoid receptor gene [17] . Mutations in one of the three ENaC (α or β or γ) subunits are causative for the systemic form of pseudohypoaldosteronism type 1 (PHA-1), a salt-losing syndrome described by Cheek and Perry [47, 7] . The majority (80%) of human PHA-1 mutations are observed in the exon 8 of the SCNN1A (αENaC) gene and only 20% in the SCNN1B (βENaC) or SCNN1G (γENaC) gene [47] . ENaC is expressed at the apical side in tight epithelia of the distal colon, in the respiratory epithelium, in principal cells of the distal tubule and the collecting duct, and in the duct of several excretory glands [34] . ENaC channel has a predominant role in sodium/potassium homeostasis and blood Electronic supplementary material The online version of this article (doi:10.1007/s00424-017-1990-2) contains supplementary material, which is available to authorized users. pressure regulation. In vivo, the constitutive knockout of each of the three ENaC subunits (α, β, γ) revealed the importance of each subunit for survival: these knockouts died soon after birth from a combined lung and renal phenotype [19, 4, 24] . Scnn1a −/− neonates failed to clear the lungs of liquid and presented a life-threatening hyperkalemia [19] . Scnn1b −/− neonates did not develop severe respiratory distress but die from hyperkalemia. Scnn1g −/− neonates died from hyperkalemia, but transiently presented problems to clear their lungs of liquid [4] . Hyperkalemia was common in all three mouse models and most likely the major cause of death. Persistent and symptomatic hyperkalemia was recently also reported in a PHA1 patient [27] . We previously performed a genetic dissection of Scnn1a gene function along the nephron [34] . Using promoters driving the expression in CD (Hoxb7) [35] , in CNT (Atp6v1b1) [30] , or in CNT and CD (aquaporin 2) [9] , αENaC subunit expression was conditionally deleted in a nephron segmentspecific manner. Surprisingly, the activity of αENaC in CD was dispensable and likely compensated by ENaC expression within CNT and/or DCT2 [35] . When αENaC-mediated sodium reabsorption was deleted in CNT and CD (aquaporin 2 promoter) [9] , the phenotype was mild and no perinatal lethality was observed thus raising the question of the importance of DCT2 with the remaining nephron segment still expressing ENaC.
In vitro, ENaC activity in oocytes is dependent on the expression of the αENaC subunit. When the αENaC subunit was expressed alone, a small but significant amiloridesensitive current was recorded, that is 1-2% of the maximum activity measured when the three subunits (α, β, γ) were coexpressed [6] . Co-expression of aβ and αγ subunit might produce 5-10% of maximal activity whereas βγ subunits had no or barely detectable activity [5] . These observations stressed the importance of αENaC as chaperone protein to bring single β, γ, or βγ subunits to the plasma membrane. This prediction was fully supported in vivo by the inducible deletion of αENaC along the entire adult nephron and the collecting duct (excluding the glomerulus) using a doxycycline-inducible system [29] . This caused a severe salt losing syndrome with life-threatening hyperkalemia if not rescued by a high-sodium and low-potassium diet. PHA-1 patients with βENaC mutation are currently treated with such a diet, and upon severe hyperkalemia cation exchange resins are applied [1] . Based on in vitro data, we predicted that the kidney without the βENaC subunit still confers a certain percentage of ENaC activity which may lead to a less severe phenotype in comparison to αENaC knockout mice.
In the present study, we addressed whether ENaC channels consisting of αγ (lacking the βENaC subunit) along the nephron generate sufficient ENaC activity to prevent lifethreatening hyperkalemia, salt wasting, and lethality characteristics of systemic PHA-1. We took advantage of an inducible nephron-specific βENaC knockout mouse model that lacks the βENaC subunit along the nephron in adulthood. Our data imply that low-potassium diet alone is necessary and sufficient to avoid severe hyperkalemia.
Methods
Generation and induction of nephron-specific Scnn1b
Pax8/LC1 mice ) mice. Genotyping of the mice was performed by PCR-based DNA analysis from ear biopsies using the following primers: Pax8-rtTA_ST1: 5′-CCATGTCTAGACTG GACAAGA-3′, Pax8-rtTA_ST2: 5′-CTCCAGGCCACATA TGATTAG-3′; LC-1 Cre3: 5′-TCGCTGCATTACCG GTCGATGC-3′; LC-1 Cre4: 5′-CCATGAGTGAACGA ACCTGGTCG-3′. The recombination of the floxed Scnn1b allele was investigated in the kidney, liver, colon, and heart by PCR analysis using the three following primers (Scnn1b allele): 35as, 5′ CTG CTC TGG GAT TAC AGG 3′; β-1as, 5′ GAT AAG GTG GGA AGA GCT GG 3′; and 36_S-2 (s), 5′ CAC TCA GGC ACA TGA TAG ACA GG 3′. If not otherwise stated, 35 cycles were run, and each run consisted of 1 min; each at 94, 56, and 72°C. The Pax8::rtTA and the TRE::LC1 transgene were detected by PCR using primers and protocols as previously described [29] .
Animals were housed in individually ventilated cages at 23 ± 1°C with 14 h day and 10 h night (breeding) and 12 h day and 12 h night cycle (experimental conditions), respectively, and with free access to food (standard diet, 0.17% sodium and 0.97% potassium, ssniff Spezialdiäten GmbH, Germany) and tap water if not otherwise stated. Animal maintenance and experimental procedures were in agreement with the federal guidelines and were approved by local authorities.
Induction with doxycycline
Following doxycycline induction (at day 0) for 2-4 days (standard diet; protocol A, Supplemental Figure 1A ), parameters like water and food consumption, urine volume and feces output, and urinary electrolytes were collected and measured. Parameters like, e.g., food intake, as well as urine volume and feces weight were measured 24 h following induction. Body weight is presented as percentage of Δ body weight changes with respect to time point of reference weight. Plasma aldosterone and the hematocrit values were determined at day 3, and plasma electrolytes were analyzed at day 4. We further applied the following diets (Supplemental Figure 1) Figure 1D ). Protocol E, Supplemental Figure 1E : one series of Scnn1b control and experimental mice were switched back to a standard diet (0.17% sodium and 0.97% potassium) at day 32 after 29 days under HNa + / LK + diet, and physiological parameters were further determined every 24 h during five consecutive days (day [29] [30] [31] [32] [33] [34] . LNa + protocol (protocol F, Supplemental Figure 1F ): Following 3 consecutive days under a standard diet, Scnn1b mice were fed with LK + diet for 16 days (between day 3 and day 19) and then were switched to a low-Na + (< 0.1% sodium) and normal-K + (0.97% potassium) diet (LNa + diet). The physiological parameters were determined every 24 h during 4 consecutive days (days [19] [20] [21] [22] [23] . Body weight, water and food consumption, urine volume, and feces output were assessed every 6 h (protocol B) or 24 h at 6 am (protocols A, C, D, E, and F). Na + and K + intake were determined as the quantity of food intake multiplied by the concentration of Na + or K + containing in the diet and normalized by the mouse body weight. At the end of the experiments, and following anesthesia with 1% isoflurane, plasma samples were collected from the retro-orbital venous plexus, followed by cervical dislocation and collection of tissues (kidney, liver, colon, and heart) that were frozen by liquid nitrogen.
Analysis of urinary and plasma electrolytes and aldosterone
Protocols A-F (Supplemental Figure 1 ): Urinary and plasma Na + and K + collected in metabolic cages were measured using a flame photometer (Cole-Parmer Instrument). Food and water intake, feces output, urine volume, and Na + and K + intake and loss were normalized to the body weight of the corresponding experimental day. Sodium balance was calculated as the ratio of sodium intake normalized to the sodium output in urine and feces. Plasma aldosterone levels were measured following standard procedures using a RIA (Coat-A-Count RIA kit; Siemens Medical Solutions Diagnostics, Ballerup, Denmark) (protocols A, C, and D, Supplemental Figure 1 ; Table 1 ). Plasma creatinine was measured at days 2 and 3 at the end of urine collections (protocol A, Supplemental Figure 1 ). Protocol A (Supplemental Figure 1 ): Urinary and serum creatinine as well as serum urea and glucose concentrations were measured at the Zurich Integrative Rodent Physiology (ZIRP) platform (University of Zurich, Switzerland). The plasma osmolality was calculated as follows: (2× [serum Na Table 2 ) [22] . The free water clearance C H 2 O ð Þ was calculated as following; C H 2 O = V − (U osm × V)/P osm, where V is urine volume (ml/min), U osm is urine osmolality, and P osm is plasma osmolality. The fractional excretion of sodium and potassium was assessed as described [12] . Plasma creatinine was measured at the end of urine collections. Plasma aldosterone concentration was measured using an RIA (Coat-A-Count RIA kit; Siemens Medical Solutions Diagnostics, Ballerup, Denmark). Mouse samples with values >1200 pg/ml were further diluted using a serum pool with a low-aldosterone concentration (<50 pg/ml).
Analysis of protein expression
Frozen tissues were homogenized and protein extracted as described [2] . Anti-βENaC and pT53-NCC antibodies were obtained and used as described [36] . Anti-pSPAK antibody was obtained from Millipore. Antibodies pSPAK was diluted 1/500. Antibodies βENaC and pNCC (T53) were diluted 1/1000. Anti-β-actin antibody (Sigma-Aldrich) was used as loading control. Protein samples of kidney lysates from SPAK KO mice were used as controls (kindly provided by O. Staub) [11, 23] . Values are given as mean ± SEM. The number of mice is indicated in parentheses. Plasma aldosterone was measured as described in the BMethods^section. For each group, experimental mice were compared to their diet-matched control mice
Ctr. control, Exp. experimental animals, n.s. not significant *P < 0.05, ***P < 0.001
Immunofluorescence
Cryosections (5 μm) of kidneys were incubated overnight at 4°C with primary antibodies against Cre (1:10,000) [20] , βENaC (1:40,000) [45] , or CaBP D28k (1:10,000) (Swant, Marly, CH). Binding sites of primary antibodies were detected by fluorescence-labeled secondary antibodies (goat anti-rabbit-CY3 (1:1000), goat anti-mouse-FITC (1:100); Jackson ImmunoResearch Laboratories, West Grove, PA). Images were acquired with a fluorescence microscope (Leica DM6000 B; Leica Microsystems) and processed by the Leica Application Suite software before importing into Adobe Photoshop CS3 (Adobe Systems, Inc., San Jose, CA) and Powerpoint for image arrangement and labeling.
Statistical analysis
All values are presented as mean ± standard error of the mean (SEM). The data were analyzed using unpaired twotailed Student's t test. Values expressed as a function of time were analyzed using multiple comparisons by twoway ANOVA (Bonferroni), Scnn1b Pax8/LC1 versus control mice. A P value less than 0.05 was considered statistically significant; *P < 0.05, **P < 0.01, ***P < 0.001.
Results
Adult nephron-specific Scnn1b-deficient mice develop a severe PHA-1 without persistent salt wasting
To determine the role of the βENaC subunit in adult kidney, Scnn1b deletion was induced with doxycycline in 4-week-old mice under a standard diet (protocol A, Fig. 1, Supplemental  Figure 1 ). Using semiquantitative PCR, we identified efficient gene targeting in the kidney but not in the heart of Scnn1b Pax8/ LC1 mice (Fig. 1a, lanes 1 and 4) . Surprisingly, we also detected recombination in the liver and colon. In the kidney, Western blot analyses revealed, already after 2 days of induction, a significant decrease of βENaC (92% of control, P < 0.01) (Fig. 1b) . This was further confirmed by immunohistochemistry (Fig. 1d) . Four days following doxycycline induction, Scnn1b
Pax8/LC1 mice presented with clinical symptoms of severe PHA1 characterized by significant loss of body weight (Fig. 2a) , lower plasma sodium, and life-threatening hyperkalemia (Fig. 2b) , accompanied by a more than tenfold increase of plasma aldosterone levels ( Table 1 ). The 24-h Na + excretion did not change between control and experimental groups (Fig. 2c) , coherent with the FE Na that did not differ amongst the groups at day 2 and day 3 (0.36% in experimental versus 0.35% in control mice and 0.89% in experimental versus 0.95% in control mice, respectively). Contrary to the Values are given as mean ± SEM. The number of mice is indicated in parentheses. For each parameter, experimental mice were compared to their corresponding control littermates
Ctr. control, Exp. experimental animals, n.s. not significant *P < 0.05, **P < 0.01, ***P < 0.001 sodium data at day 2, there was no change of 24-h K + excretion but a significant decrease of potassium excretion at days 3 and 4 (Fig. 2d) . The FE K was significantly decreased at days 2 and 3 (22.7% in experimental versus 33.2% in control mice, P < 0.05, and 33.1% in experimental versus 66.8% in control mice, P < 0.001, respectively).
Body weight loss was accompanied by progressive decrease in food (Supplemental Figure 2A ) and water intake (Supplemental Figure 2B) , and experimental animals presented with decreased feces (Supplemental Figure 2C ) and urine output (Supplemental Figure 2D) . Consistent with the dramatic decrease in food intake (Supplemental Figure 2A) , the 24-h Na + (Supplemental Figure 2E ) and K + intake (Supplemental Figure 2F ) was significantly decreased at 3 and 4 days after doxycycline induction. Scnn1b
Pax8/LC1 mice presented a severe pseudohypoaldosteronism phenotype with severe dehydration, significantly increased hematocrit and plasma osmolalities, and increased plasma urea values whereas plasma glucose, and urine volume and osmolality were not different between the groups ( Table 2 ). The ratio of urine to plasma osmolality (U/P osm ) and the creatinine clearance were not significantly altered. The free water clearance was negative in both control and experimental mice, i.e., knockout mice are still able although less efficient to concentrate the urine than control littermates (Table 2 ). Pax8/LC1 mice. a DNA-based genotyping using (a) on extracts from the kidney, liver, and heart from Scnn1b controls (Ctr., lanes 2 and 3) and experimental (Scnn1b To assess if the severe hyperkalemia in Scnn1b Pax8/LC1 mice can be rescued, mice were induced by doxycycline and kept for 3 days under a standard diet and then switched to a high-Na + and low-K + diet. Plasma and urinary electrolytes were collected to assess the physiological parameters (protocol B, Supplemental Figure 1 ). Scnn1b
Pax8/LC1 mice significantly lost weight after the second day (Fig. 3a) , but the high-Na + and low-K + diet stabilized the body weight (Fig. 3a) . Plasma K + concentration was not affected, whereas the experimental mice presented a slight but significant lower plasma sodium concentration (Fig. 3b) . Upon this diet, Scnn1b
Pax8/LC1 mice nearly normalized their food and water consumption, feces output, urine volume, and sodium and potassium excretion as well as their sodium and potassium intake (Supplemental Figure 3) .
We further followed the Scnn1b Pax8/LC1 mice upon a prolonged high-Na + and low-K + diet (protocol C, Supplemental Figure 1 ). Scnn1b
Pax8/LC1 mice stabilized their body weight (Supplemental Figure 4A ) and became normokalemic (5 mmol/l), although their plasma sodium concentration remained slightly but significantly lower (Supplemental Figure 4B ). The 24-h urinary Na + and K + excretion as well as Na + and K + intake did not differ (Supplemental Figure 4C-F) . Physiological parameters like food and water intake, feces weight, and urine volume did not differ between the groups (Supplemental Figure 5) . Under both standard and HNa + /LK + diets, protein expression of both αENaC and γENaC did not differ between control and experimental mice (Supplemental Figure 6 ). Switching to a standard diet (protocol E, Supplemental Figure 1 ) reinitiated the severe hyperkalemic PHA-1 phenotype without persistent salt wasting (data not shown). In summary, the life-threatening hyperkalemia is normalized in Scnn1b
Pax8/LC1 mice upon a high-sodium and lowpotassium diet, and nearly 80% (20 of 24) of the experimental mice are rescued. No salt wasting was observed under highsodium and low-potassium diet in both groups.
Hyperkalemia determines NCC expression in Scnn1b
Pax8/LC1 mice
To analyze whether deletion of the βENaC subunit in adult kidney might have any effect on NCC regulation, we further tested total and phosphorylated NCC in kidney cortex extracts from Scnn1b Pax8/LC1 mice kept under standard (protocol A) and HNa + /LK + diet (protocol B) (Fig. 3) . Under standard diet, Scnn1b
Pax8/LC1 mice show a striking downregulation of both the total and the phosphorylated (T53) form of NCC expression (Fig. 3c, d ). Upon HNa + /LK + diet, the pT53-NCC but not the total NCC protein expression from Scnn1b
Pax8/LC1 mice is normalized (Fig. 3e, f) . The phosphorylation of SPAK (Supplemental Figure 7) followed the same expression pattern as that of pT53-NCC (Fig. 3) .
Since we did not observe persistent salt wasting, HNa + may not be necessary to rescue the Scnn1b Pax8/LC1 mice. Interestingly, a LK + diet (with standard Na + ) (protocol D, Supplemental Figure 1 ) efficiently normalized all physiological parameters, like body weight (Fig. 4a) , plasma electrolyte concentrations (Fig. 4b) as well as food and water intake, feces output, and urinary volume (Supplemental Figure 8) . The daily Na + and K + excretion (Fig. 4c, d ) did not differ between control and experimental mice. Standard Na + but LK + diet rescues the phosphorylated form of NCC but not the total NCC protein expression (Fig. 4e, f) . Only the potassium binder kayexalate with a K + -deficient diet normalizes both total and phosphorylated NCC protein expression (Fig. 4g, h ).
Whereas standard (Na + and K + ) diet decreased phosphorylated SPAK levels (Supplemental Figure 7A) Pax8/LC1 experimental mice, which were efficiently rescued (Supplemental Figure 9) . Severe hyperkalemia thus correlates with an aldosterone-independent decrease of NCC protein expression. Low-potassium diet alone is necessary and sufficient to avoid severe hyperkalemia and to rescue the phosphorylated form of NCC protein expression.
Scnn1b knockout mice present a transient salt wasting phenotype under LNa + diet
To further determine the role of the βENaC subunit in sodium balance, control and experimental Scnn1b mice were rescued with standard sodium but low-potassium (LK + ) diet for 16 days and then switched to a standard potassium but lowsodium (LNa + ) diet (protocol F, Supplemental Figure 1,  Fig. 5 ). This reinitiated the PHA-I phenotype with body weight loss (Fig. 5a) , lower plasma sodium concentration, and hyperkalemia (Fig. 5b ), but only a transient salt wasting that is normalized at days 2 and 3 after the switch (Fig. 5c) . The 24-h K + excretion was significantly decreased at day 3 after the switch to LNa + diet (day 23) (Fig. 5d) . Consistent with the body weight loss, a decrease of food intake was observed at day 3 after the switch to LNa + diet (day 23) (Supplemental Figure 10A) . The water intake, feces weight, and urine volume did not differ between the groups (Supplemental Figure 10B-D) . Consistent with the decrease in food intake (Supplemental Figure 10A) , the 24-h Na + (Supplemental Figure 10E ) and K + intake (Supplemental Figure 10F) were significantly decreased at day 3 after the switch to LNa + diet (day 23). A switch to a low-Na + and standard-K + diet (protocol F, Supplemental Figure 1 ) reinitiated the downregulation of NCC total and pT53-NCC protein expression levels in Scnn1b
Pax8/LC1 mice (Fig. 6 ). Pax8/LC1 mice. a Body weight changes (Δ body weight, BW) of control and experimental mice (each group, n = 6) in percentage of initial BW upon standard and short-term high-Na + and low-K + diet (protocol B). b Measurements of plasma Na + and K + concentrations (mmol/l) in control (n = 6) and experimental mice (n = 5) at 30 h following diet switch. c, e Representative Western blot analyses of NCC, pNCC, and actin on kidney cortex extracts from control and experimental Scnn1b mice upon standard diet (c) protocol A, control, n = 5, and experimental mice, n = 6; e upon short-term high-Na + and low-K + diet, protocol B, in control, n = 5, experimental mice, n = 5. d, f Quantification of proteins from corresponding Western blot analyses. Protein levels are normalized to actin and expressed in percentage of control. Results are presented as mean ± SEM and data were analyzed by unpaired t test. *P<0.05, *** P <0.001 experimental group (at day 23) (0.5 (±0.23)μmol in experimental versus 0.84 (±0.32)μmol in control mice). While sodium output (urine and feces) did not differ between the control and experimental group, the sodium intake was excretion (mmol/24 h/gBW) in control and experimental mice (each group, n = 6). Representative Western blot analyses of the total NCC, pNCC, and actin levels e in kidney cortex extracts from control and experimental Scnn1b mice upon low-K + diet (protocol D, control, n = 5; experimental mice, n = 5). f Quantification of proteins from corresponding Western blot analyses. Protein levels are normalized to actin and expressed in percentage of control. g Representative Western blot analyses of total NCC, pNCC, and actin levels in kidney extracts from control and experimental Scnn1b mice treated for 2 weeks upon doxycycline and K + -deficient diet with kayexalate (poly(sodium 4-styrenesulfonate) (Sigma-Aldrich) mixed with the food (0.96 μl/day/ gBW)) (each group, n = 4). h Quantification of proteins from corresponding Western blot analyses. Protein levels are normalized to actin and expressed in percentage of the control. Results are presented as mean ± SEM and data were analyzed by unpaired t test. * P<0.05 severely decreased in KO animals (Fig. 7) . In summary, the Scnn1b
Pax8/LC1 mice present hyperkalemia and a transient salt wasting when challenged with a low-Na + and standard-K + diet.
Discussion
Acute nephron-specific gene deletion of the βENaC subunit induces life-threatening hyperkalemia without persistent salt wasting Efficient deletion of tubular βENaC subunit is observed already after 2 days of doxycycline treatment with a residual protein pool of about 8% (Fig. 1) . This is consistent with few cells still expressing βENaC (Fig. 1) and may reflect the short in vitro half-life of total ENaC protein as measured in MDCK cells [37] . Adult nephron-specific Scnn1b Pax8/LC1 mice developed a life-threatening PHA-I similar to the Scnn1a Pax8/LC1 mice [29] , although without persistent salt wasting under standard sodium concentration in the diet (Fig. 2) . A saltdependent PHA-I even under low-sodium condition is also observed in mice exhibiting a constitutive and decreased βENaC protein expression [31] . The primary event is seen when Scnn1b
Pax8/LC1 mice increase Na + loss on the first day under low-salt (day 21, Fig. 5c ) diet that is accompanied by decrease of food intake ( Fig. 8 and Supplemental Figure 9 ). Furthermore, as in the Scnn1a
Pax8/LC1 mice [29] , our data clearly demonstrate that an acute genetic deletion of the βENaC subunit cannot be compensated by residual ENaC activity through αγENaC channels (Fig. 2) . Mice exhibit a dramatic weight loss upon standard diet and the βENaC- Pax8/LC1 mice. Representative Western blot analyses of total NCC, pNCC, and actin levels a in kidney extracts from control and experimental Scnn1b mice upon low-Na + diet (protocol F, control, n = 6 and experimental mice, n = 4). b
Quantification of proteins from corresponding Western blot analyses. Protein levels are normalized to actin and expressed in percentage of control. Results are presented as mean ± SEM and data were analyzed by unpaired t test. ** P <0.01 induced PHA-I phenotype is reinitiated by returning to either a standard diet (data not shown) or a standard-potassium but low-sodium diet (Fig. 5) . While KO mice presented normal diuresis the third day after induction (Table 2) , the fourth day showed almost anuric mice (Fig. 2) . Indeed, Scnn1b
Pax8/LC1 mice got rapidly and severely sick, consistent with the loss in body weight and the decrease in food intake (Supplemental Fig. 2) . Likewise, acute pharmacological blockade of ENaC by amiloride on a low-salt diet was life-threatening in rats confirming no compensatory mechanisms when ENaC is pharmacologically blocked along the ASDN [14] . These data revealed a severe hyperkalemia and a severe decrease of sodium intake with an impaired of water homeostasis in the experimental mice.
Standard-sodium but low-potassium diet efficiently corrects the kalemia of Scnn1b
Pax8/LC1 mice in a pNCC-dependent manner
Scnn1b
Pax8/LC1 mice are rescued by high-or standard-sodium/low-potassium diet It is conceivable that high plasma potassium concentration as found in Scnn1b
Pax8/LC1 mice plays a determinant role either by its depolarizing effect on membrane potential in heart or on skeletal muscle [13, 16] . Hyperkalemia in humans suffering from PHA-1 is life-threatening leading to cardiac arrhythmia and ultimately cardiac arrest [27, 32] . Furthermore, we asked the question whether low-potassium (and standard-sodium) diet would be sufficient to rescue the βENaC-induced PHA-I phenotype. Indeed, a low-potassium diet alone was sufficient to rescue the Scnn1b
Pax8/LC1 mice for more than 25 days (Fig. 4, Supplemental Figure 8 ), highly suggesting a differential role of sodium and potassium in NCC regulation. It has been demonstrated that potassium loading itself induces a PHA-1 phenotype in a mouse model with reduced αENaC expression within the CNT [30] , where baseline ENaC-mediated sodium transport was the highest and largely aldosterone-independent [26] .
Severe hyperkalemia correlates with the decrease in phosphorylation of the SPAK-NCC pathway While the total NCC protein expression is normalized in Scnn1a
Pax8/LC1 mice treated with a HNa + /LK + diet [29] , total NCC is significantly Pax8/LC1 mice under lowsodium diet. Sodium balance under low-Na + diet is illustrated as the ratio of sodium intake (gray bar), normalized to the sodium output in urine (white bar), or feces (black bar) at day 23. Data were taken from mice under low-Na + diet in experiments (sodium intake; Supplemental Figure 10 , fecal sodium (BResults^section) and urinary sodium (Fig. 5)) downregulated in Scnn1b
Pax8/LC1 mice independently of sodium-and potassium-containing diets (Figs. 3 and 4) but dependent of potassium binder (kayexalate) treatment. Thus, the regulation of total NCC is diet-independent whereas its phosphorylation is diet-sensitive in Scnn1b
Pax8/LC1 mice (Figs. 3, 4, and 6) . Interestingly, the two higher values of plasma potassium concentration under HNa + /LK + diet (Fig. 8b) originate from the two Scnn1b
Pax8/LC1 mice that present a severe reduction of phosphorylated NCC protein expression (Fig. 3e) . This is not consistent with obtained data from the Scnn1a
Pax8/LC1 mice [29] , since all Scnn1a
Pax8/LC1 mice normalized both the total and the phosphorylated form of NCC. This suggests a different role of αENaC and βENaC subunits in the NCC regulation. Furthermore, the observed decrease in pNCC under standard diet is linked to severe hyperkalemia in Scnn1b Pax8/LC1 mice (Fig. 8a) . Switching from a standard-K + diet to a low-K + diet showed that plasma potassium drove changes in pNCC abundances (Fig. 4) , while kayexalate treatment allowed the normalization of both total and phosphorylated NCC protein expression (Fig. 4) . This reveals an aldosterone-independent and potassiumdependent pNCC regulation. Interestingly, LK + diet normalizes plasma potassium concentration and the pNCC protein expression of Scnn1b
Pax8/LC1 mice (Fig. 8c) . In addition, while the ratio between pNCC to NCC is decreased under standard diet, a HNa + /LK + diet normalizes and a standard Na + /LK + increases this ratio (data not shown). Switching to a LNa + but standard-K + diet reinitiates a negative relationship between the plasma potassium concentration and the abundance of the pNCC expression (Fig. 8d) . This was also demonstrated through an acute oral K + loading in aldosteronedeficient mice [36] or potassium loading in a mouse model with reduced αENaC expression in the CNT [30] . Recently, several groups [28, 39] have demonstrated a negative linear relationship between the plasma potassium concentration and the abundance of the phosphorylated form of NCC. As a consequence, hyperkalemia increased the distal delivery of sodium by decreasing NCC activity allowing secretion of potassium through ROMK [3] . Overall, the observed rescue of Scnn1b
Pax8/LC1 mice through a standard-sodium but low-K + diet (Fig. 4, Supplemental Figure 8 ) is consistent with reports showing that a high-sodium diet might rather further decrease NCC phosphorylation [8] and that a low-potassium diet presents a strong stimulus to increase total and phosphorylated NCC [15, 41] , even in Na + -repleted mice [43] . It has been proposed that the accompanying anions of sodium, like chloride or citrate, furthermore regulate pNCC in response to high-K + diet, and thus acidic high-K + diet may reduce urinary K + loss [10, 46] . We thus do not exclude a possible role of chloride in the regulation of NCC activity in our βENaC-deficient model. Interestingly, in wild-type mice high-sodium and lowpotassium (Western) diet results in an aldosterone and angiotensin-independent increase of NCC activity via the with-no-lysine kinase (WNK)-SPAK pathway [43] , although other kinases may be involved [44] . Consistent with published data [21, 33, 42] , we have shown a reduction of the phosphorylation of SPAK that follows the downregulation of pNCC (Supplemental Figures 7 and 9 ). Our data confirm that SPAK-NCC regulation is tightly regulated through potassium diet. In summary, our study demonstrates that adult βENaC subunit expression in DCT2/CNT/CD is required for primarily modulating the daily potassium homeostasis. We found a minor and transient role of the βENaC subunit in sodium homeostasis that may only be needed when chronically challenged upon low-salt diet. In human, systemic PHA-I only ameliorates after 6 years of continuous treatment, whereas renal PHA-I rapidly improves after infancy [18] . Our data further unveiled the need of rapid plasma potassium correction to ensure survival. It may be interesting to study whether compensatory mechanism develop in the long term (months) and our mice may provide a suitable model to address this issue. For human PHA-1 patients, it may be considered to include in addition to high-salt intake (up to 30 g/day) a low-potassium diet and/or potassium chelation either acutely (e.g., through kayexalate [38] ) or chronically through newly developed potassium binders (e.g., patiromer). The daily control of plasma potassium concentration is thus mandatory.
